World Congress on Organ Transplantation and Artificial Organs August 24-25, 2018 Tokyo , Japan

Track 1:  Organ Transplantation Surgery

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

Related Conferences

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018 Tokyo, Japan 37th Asia-Pacific Nursing and Medicare Summit, October 20-21, 2017 Osaka, Japan; 6th Annual Congress & Medicare Expo on Primary Healthcare, May 14-16, 2018 Tokyo, Japan, 30th Global Experts Meeting on Neonatal Nursing and Maternal Healthcare, May 14-16, 2018 Singapore; 7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain.Canadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore.

Track 2. Heart Transplant Surgery & Artificial Heart

A heart transplant, or a cardiac transplant, is a surgical transplant procedure performed on patients with end-stage heart failure or severe coronary artery disease when other medical or surgical treatments have failed. As the most common procedure is to take a functioning heart from a recently deceased organ donor, and implant it into the patient. An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. An artificial is distinct from a ventricular assist device designed to support a failing heart. It is also distinct from a cardiopulmonary bypass machine, which is an external device used to provide the functions of both the heart and lungs and are used only for a few hours at a time, most commonly during cardiac surgery.

Related Conferences

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018 Tokyo, Japan 37th Asia-Pacific Nursing and Medicare Summit, October 20-21, 2017 Osaka, Japan; 6th Annual Congress & Medicare Expo on Primary Healthcare, May 14-16, 2018 Tokyo, Japan, 30th Global Experts Meeting on Neonatal Nursing and Maternal Healthcare, May 14-16, 2018 Singapore; 7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAECanadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia

Track 3. Liver Transplantation & Bio Artificial Liver

Liver transplantation or hepatic transplantation is the replacement of a diseased liver with the healthy liver from another person. Liver transplantation is a treatment option for end-stage liver disease and acute liver failure, although availability of donor organs is a major limitation. The most common technique is orthotopic transplantation, in which the native liver is removed and replaced by the donor organ in the same anatomic position as the original liver. The surgical procedure is complex, requiring careful harvest of the donor organ and meticulous implantation into the recipient. Liver cells obtained from an animal were used instead of developing a piece of equipment for each function of the liver. The structure and function of the first device resembles that of today's BALs. Animal liver cells are suspended in a solution and a patient's blood is processed by a semi permeable membrane that allows toxins and blood proteins to pass but restricts an immunological response.

Related Conferences

6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE. The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing, International Society for Organ Donation and Procurement, International Society for Heart and Lung Transplantation

Track 4. Tissue Engineering & Regenerative Medicine

Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a scaffold for the formation of new viable tissue for a medical purpose. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance it can be considered as a field in its own. While most definitions of tissue engineering cover a broad range of applications, the tissues involved require certain mechanical and structural properties for proper functioning. The term has also been applied to efforts to perform specific biochemical functions using cells within an artificially-created support system. The term regenerative medicine is often used synonymously with tissue engineering, although those involved in regenerative medicine place more emphasis on the use of stem cells or progenitor cells to produce tissues.

Related Conferences

7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria. The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing, International Society for Organ Donation and Procurement, International Society for Heart and Lung Transplantation

Track 5. Kidney Transplantation & Artificial Kidney Dialysis

Kidney transplantation or renal transplantation is the organ transplant of a kidney into a patient with end-stage renal disease. Kidney transplantation is typically classified as deceased-donor or living-donor transplantation depending on the source of the donor organ. Living-donor renal transplants are further characterized as genetically related or non-related transplants, depending on whether a biological relationship exists between the donor and recipient. Hemodialysis is a method for removing waste products such as creatinine and urea, as well as free water from the blood when the kidneys are in kidney failure. The mechanical device used to clean the patients’ blood is called a dialyzer, also known as an artificial kidney. The other name for artificial kidney is also called a dialysis machine. Modern dialysers typically consist of a cylindrical rigid casing enclosing hollow fibers cast or extruded from a polymer or copolymer, which is usually a proprietary formulation.

Related Conferences

37th Asia-Pacific Nursing and Medicare Summit, October 20-21, 2017 Osaka, Japan; 6th Annual Congress & Medicare Expo on Primary Healthcare, May 14-16, 2018 Tokyo, Japan, 30th Global Experts Meeting on Neonatal Nursing and Maternal Healthcare, May 14-16, 2018 Singapore; 7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, SpainCanadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia

Track 6. Lungs Transplantation & Artificial Lungs

Lung transplantation or pulmonary transplantation is a surgical procedure in which a patient's diseased lungs are partially or totally replaced by lungs which come from a donor. Donor lungs can be retrieved from a living donor or a deceased donor. A living donor can only donate one lung lobe. With some lung diseases a recipient may only need to receive a single lung. With other lung diseases such as cystic fibrosis it is imperative that a recipient receive two lungs. While lung transplants carry certain associated risks, they can also extend life expectancy and enhance the quality of life for end-stage pulmonary patients. An artificial lung is a prosthetic device that provides oxygenation of blood and removal of carbon dioxide from the blood. The AL is intended to take over some of the functionality of biological lungs. It is different from a heart-lung machine in that it is external and designed to take over the functions of the lungs for long periods of time rather than on a temporary basis.

Related Conferences

5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE, Canadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia

Track 7. Abdominal Organ Transplantation

Abdominal organ transplantation, specifically liver, kidney and pancreatic transplantation, has experienced a tremendous growth over the last two decades. With this growth comes a need for a general, standardized introduction for those healthcare professionals involved with this branch of medicine. This manual is a readily-available, concise reference for the professional involved in the field of abdominal organ transplantation as well as the lay person.

Related Conferences

5th Asia Pacific Gynecology and Obstetrics Congress, August 22-23, 2018 Tokyo, Japan 37th Asia-Pacific Nursing and Medicare Summit, October 20-21, 2017 Osaka, Japan; 6th Annual Congress & Medicare Expo on Primary Healthcare, May 14-16, 2018 Tokyo, Japan, 30th Global Experts Meeting on Neonatal Nursing and Maternal Healthcare, May 14-16, 2018 Singapore; 7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE. Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing

Track 8. Pediatric Organ Transplantation

Pediatric organ donation and organ transplantation can have a significant life-extending benefit to the young recipients of these organs and a high emotional impact on donor and recipient families. Pediatricians, pediatric medical specialists, and pediatric transplant surgeons need to be better acquainted with evolving national strategies that involve organ procurement and organ transplantation to help acquaint families with the benefits and risks of organ donation and transplantation. Efforts of pediatric professionals are needed to shape public policies to provide a system in which procurement, distribution, and cost are fair and equitable to children and adults.

Related Conferences

7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria. Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing, International Society for Organ Donation and Procurement, International Society for Heart and Lung Transplantation, International Registry in Organ Donation and Transplantation.

Track 9. Pancreas Transplant Surgery for Diabetes

A pancreas transplant is an organ transplant that involves implanting a healthy pancreas into a person who usually has diabetes. Because the pancreas is a vital organ, performing functions necessary in the digestion process, the recipient's native pancreas is left in place, and the donated pancreas is attached in a different location. In the event of rejection of the new pancreas, which would quickly cause life-threatening diabetes, there would be a significant chance the recipient would not survive very well for long without the native pancreas, however dysfunctional, still in place. The healthy pancreas comes from a donor who has just died or it may be a partial pancreas from a living donor. At present, pancreas transplants are usually performed in persons with insulin-dependent diabetes, who can develop severe complications.

Related Conferences

4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE ; Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy 18th Annual Congress 2017 (APAGE 2017) :15th Congress of the European Society of Contraception and Reproductive Health, May 09- 12,2018 at Budapest, Hungary. The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing, International Society for Organ Donation and Procurement, International Society for Heart and Lung Transplantation

Track 10. Transplant Rejection

Immune system usually protects you from substances that may be harmful, such as germs, poisons, and sometimes, cancer cells. These harmful substances have proteins called antigens coating their surfaces. As soon as these antigens enter the body, the immune system recognizes that they are not from that person's body and that they are "foreign," and attacks them. When a person receives an organ from someone else during transplant surgery, that person's immune system may recognize that it is foreign. This is because the person's immune system detects that the antigens on the cells of the organ are different or not "matched." Mismatched organs, or organs that are not matched closely enough, can trigger a blood transfusion reaction or transplant rejection. To help prevent this reaction, doctors type, or match both the organ donor and the person who is receiving the organ. The more similar the antigens are between the donor and recipient, the less likely that the organ will be rejected.

Related Conferences

6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE. Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing

Track 11. Skin & Tissue Grafting

Skin grafts are often employed after serious injuries when some of the body's skin is damaged. Surgical removal of the damaged skin is followed by skin grafting. The grafting serves two purposes reduce the course of treatment needed, and improve the function and appearance of the area of the body which receives the skin graft. There are two types of skin grafts the more common type is where a thin layer is removed from a healthy part of the body like peeling a potato, or a full thickness skin graft, which involves pinching and cutting skin away from the donor section. Grafting refers to a surgical procedure to move tissue from one site to another on the body, or from another creature, without bringing its own blood supply with it. Instead, a new blood supply grows in after it is placed.

Related Conferences

7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria, Canadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia

Track 12. Uterus & Ovarian Transplantation

The uterine transplant is the surgical procedure whereby a healthy uterus is transplanted into an organism of which the uterus is absent or diseased. As part of normal mammalian sexual reproduction, a diseased or absent uterus does not allow normal embryonic implantation, effectively rendering the female infertile. This phenomenon is known as absolute uterine factor infertility. Uterine transplant is a potential treatment for this form of infertility. He procedure is to take a part of the ovary and carry out slow freezing before storing it in liquid nitrogen whilst therapy is undertaken. Tissue can then be thawed and implanted near the fallopian, either orthotropic or heterotopic where it starts to produce new eggs, allowing normal conception to take place. A study of 60 procedures concluded that ovarian tissue harvesting appears to be safe.

Related Conferences

4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE ; Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy 18th Annual Congress 2017 (APAGE 2017) :15th Congress of the European Society of Contraception and Reproductive Health, May 09- 12,2018 at Budapest, Hungary. The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing, International Society for Organ Donation and Procurement, International Society for Heart and Lung Transplantation

Track 13. Solid Organ Transplant

The field of solid organ transplantation has seen significant advances in surgical techniques, medical diagnosis, selection process. Despite these advances, however, there remains a significant imbalance between the supply of organs available for transplant and the number of patients registered on transplant waiting lists. Notably, the past decade has shown gradual increases in the number of candidates waiting for a kidney, while the number of transplants performed. The waiting list for heart transplants has been the most rapidly growing list. Fortunately, policies designed to improve procurement, screening, and distribution are helping to make transplantation more efficient and organs more accessible, allowing sicker patients to undergo transplants more quickly.

Related Conferences

4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE ; Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy 18th Annual Congress 2017 (APAGE 2017) :15th Congress of the European Society of Contraception and Reproductive Health, May 09- 12,2018 at Budapest, Hungary. Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing, International Society for Organ Donation and Procurement, International Society for Heart and Lung Transplantation, International Registry in Organ Donation and Transplantation. 

Track 14. Stem Cell Transplantation

Mesenchymal stem cells are multipotent cells found in multiple human adult tissues including bone marrow, synovial tissues, and adipose tissues. Since they are derived from the mesoderm, they have been shown to differentiate into bone, cartilage, muscle, and adipose tissue. MSCs from embryonic sources have shown promise scientifically while creating significant controversy. As a result, many researchers have focused on adult stem cells, or stem cells isolated from adult humans that can be transplanted into damaged tissue. Because of their multi-potent capabilities, mesenchymal stem cell  lineages have been used successfully in animal models to regenerate articular cartilage and in human models to regenerate bone. Recent research demonstrates that articular cartilage may be able to be repaired via percutaneous introduction of mesenchymal stem cells.

Related Conferences

4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE ; Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy 18th Annual Congress 2017 (APAGE 2017) :15th Congress of the European Society of Contraception and Reproductive Health, May 09- 12,2018 at Budapest, Hungary. Canadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia

Track 15. Retinal Transplantation & Regeneration

Retinal prostheses for restoration of sight to patients blinded by retinal degeneration are being developed by a number of private companies and research institutions worldwide. The system is meant to partially restore useful vision to people who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa or age-related macular degeneration. Three types of retinal implants are currently in clinical trials The two most well-studied mechanisms of retinal regeneration are cell-mediated regeneration and cellular transplantation. Regenerative processes may have applications in humans for treating degenerative retinal diseases such as retinitis pigmentosa.

Related Conferences

6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE. Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing

Track 16. Transplantation Ethics

The field of transplant ethics is a specialty within the practice of clinical ethics.  The goals of transplant ethics are to promote the integrity of transplant medicine, and the welfare of living donors and organ recipients.  Because organs are very scarce and a precious gift, transplant ethics aims for organ allocation to those with the capacity to benefit from it. There are many ethical dilemmas and complex situations that can arise during transplant and organ donation, Ethics assessment of fulminant patients, Transplantation for those who are uninsured or underinsured, Assessment of patients expressing ambivalence about pursuing transplant, Assessment of patients with compliance problems.

Related Conferences

7th World Congress on Midwifery and Women’s Health, May 14-15, 2018 Singapore; 5th World Congress on Hospice and Palliative Care, July 16-17, 2018 Melbourne, Australia; 6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria, Canadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia

Track 17. Bio materials in Artificial Organs

An attempt is made to review the fundamental aspects of blood material interactions at the interface and how such concept may be useful in the development of biomedical devices such as small diameter vascular graft, artificial heart, heart valve and drug delivery systems based on micro/nanoparticles. The issues related to technology development, transfer, possible future changes and necessity of regulatory aspects would also be discussed. There may be bioactive materials that can induce healing even in the absence of collagen with optimum adjustment of porosity with respect to its applications and help in the reconstruction of tissues and organs to an almost indistinguishable level.

Related Conferences

6th Annual WNC for 2018, July 23-24,  2018 Singapore;  Annual Conference on Nursing, Healthcare and Disease Management, November 20-22, 2017 Dubai, UAE; Internal Medicine & Primary Care, November 9-12, 2017 Chicago, USA; General Practitioner Conference & Exhibition, November 10-12,2017 Melbourne, Australia, 4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE. The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia, National Transplant Resource Centre, Singapore, National Organ Transplant Unit, Japan, Japan Organ Transplant Network, Korea: Konos Korean Network for Organ Sharing, International Society for Organ Donation and Procurement, International Society for Heart and Lung Transplantation

Track 18. Trends in Organ Transplantation

Presumed consent legislation produces more donors and in particular more organs per donor. In cadaveric donation, the number of elderly donors is increasing, so the quality of organs available is getting poorer. There will be no substantial rise in transplantation unless there is a major breakthrough in the current programs. There will be an increase in the proportion of living related donors and debate about ethics of transplantation. Adverse publicity and debate may affect cadaveric donation and refusal rates The number of kidneys, livers and other body parts surgeons are harvesting through a controversial approach to organ donation has started to rise rapidly, a trend that is saving the lives of more waiting patients but, some say, risks sacrificing the interests of the donors.

Related Conferences

4th International Conference on Gynecology & Obstetrics , October 02-04, 2017 at Barcelona, Spain ; Annual Physicians Meeting 2018 , March 21-23, 2018 at Dubai, UAE; 20th Biennial International Meeting of the European Society of Gynaecological Oncology, Nov 04 -07,2017 at Vienna, Austria ; 20th International Conference on Gynecology and Obstetrics , Jan 22-23,2018 at Amsterdam, The Netherlands ;  World Congress on Gynecology and Obstetrics , April 16-17,2018 at Dubai, UAE ; Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy 18th Annual Congress 2017 (APAGE 2017) :15th Congress of the European Society of Contraception and Reproductive Health, May 09- 12,2018 at Budapest, Hungary. Canadian Society of Transplantation, American Society of Transplantation, BC Transplant Society, American Society of Transplant Surgeons, British Transplantation Society, Indian Society Of Organ Transplantation, Intestinal Rehabilitation and Transplant Association, The Transplantation Society, Transplant Recipients International Organization, Transplantation Society of Australia and New Zealand , Australia, Organ and Tissue Authority, Philippines, National Kidney and Transplant institute, Malaysia.

Importance and scope

Organ transplant immunosuppressant drugs are the category of drugs which are administered to minimize the chances of organ rejection after transplantation. When a person undergoes any transplantation, the body recognizes the transplant as a foreign tissue and attacks it, resulting in rejection. These drugs dilute the immune system, hence reducing the reaction towards the transplant. The factors driving this market include the advancements made in tissue engineering and organ transplantations. These transplantations help in survival of many patients as well as enhance the quality of life. The lack of availability of organs and high cost of transplantation are the limitations for the growth of this market. The increase in use of tissue engineering for generation of implants provides growth opportunity to this market.

Organ transplant immunosuppressant drugs market has accelerated the growth of rapid organ transplant by reducing the harmful side effects such as autoimmune diseases. These novel drug therapies are strategically analyzed in the report in order to provide comparative benefits. The report is also focusing on the regulatory issues and commercial mandate that are hindering the growth. Porter’s five forces model is strategically analyzed in the report to project current and future market scenarios. The value chain analysis of the organ transplant immunosuppressant drugs market is dealt strategically. Top wining strategies adopted by the key players competing in this market are critically analyzed through primaries.

Value of Organ Transplantation and Artificial Organs in Society

Transplantation in Number of Procedures. The global and regional markets for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments - Organ Transplantation (Heart, Kidneys, Liver, Pancreas, and Lungs). The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research

At least 79,950 kidney transplants done in 2014.

*Kidney transplants are done in 99 countries.

* 27,397 donations were reported from dead persons in 2014. Currently there are 77 countries worldwide with deceased donation programmes

* About 119,900 solid organs were transplanted worldwide in 2014, an increase of 1.8 per cent since 2013

*26,150 liver transplants were done worldwide in 2014. Liver transplants are performed in 74 countries

* 119,873 organs transplanted annually (2014)

* 27,397 actual deceased organ donors in 2014

* 13.6 transplants per hour done in 2014

* In 2012, the UAE did 19 kidney transplants from living donors and 28 in 2013 - Data from Global Observatory on Donation and Transplantation

The global transplantation market is expected to reach USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant products such as tissue products, immune suppressants, and organ preservation solutions is a major factor anticipated to boost growth of the market during forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for management of organ failure. Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives. The organ and tissue transplantation market in the U.S. is estimated at $11.7 billion in 2005 and is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010.The transplantation market is estimated at just under $5 billion in 2005 and is expanding at an AAGR of 4.8%.The fastest growing sector is small bowel (intestine) transplantation. Kidney and liver transplantation will account for 78% of the total in 2005.The U.S. tissue transplantation market totaled about $6.8 billion in 2005. It is projected to grow at an AAGR of 5.5%, to $8.9 billion in 2010.

Why Tokyo?

The Japanese health ministry has begun a joint research project with transport authorities in an effort to get a handle on the trade. But the government is likely to find it difficult to stop desperate people who have money from making the short plane hop to China. As Hokamura says: "I was on dialysis for four years.Hokamura negotiated the deal through a Japanese broker in Shenyang that operates under the name of the China International Organ Transplant Center which maintains a professional website with detailed information about their services for donors in English, Japanese, Korean and Russian. The website, provides the following information on the sources of organs: If you send your personal data to this center by e-mail or fax and accept the necessary body examination in Shenyang, China in order to assure a suitable donor, it may take only one month to receive a liver transplantation , the maximum waiting time being two months. As for the kidney transplantation, it may take one week to find a suitable donor, the maximum time being one month. Although the procedure to select a donor is very strict, the transplant operation will be terminated if the doctor discovers that there is something wrong with the donor's organ.” The source of the organs, however, is not specified. 

 Organ Transplants in Japan

Many patients in Japan are bitter about the underdeveloped state of transplant health in a country that has seen less than 50 cases of donated organs since the revised 1997 Organ Transplant Law. “Doctors in Japan are happy with their patients being on dialysis because it is profitable,” claims Hokamura. “They get 5.1 million yen a year to treat people like me.”According to health ministry statistics, there have been a total of 998 kidney transplants in Japan but the bulk of these -- 800 – have been from living persons. The rest are from people who died of brain death or whose heart stopped. A single death can on average now save 10 people, but there are still far too few donors and with 12,000 patients waiting for matching donors, according to the Japan Organ Transplant Network, the government is again preparing to revise the law. Meanwhile, increasing numbers of Japanese are turning to China. Sources say the cost of a kidney transplant in China runs to US$66,500 and a liver up to US$157,000. A Taiwanese broker called Yeson Healthcare Service Network recently told the Japan Times that a heart transplant at the Zhongshan Hospital in Shanghai can be had for as little as US$119,000, a fraction of the US$860,000 such an operation would cost in North America.

Why  to attend???

 The significance of human life and organs. Organ Transplantation is essential for us. Heart, Kidney, Liver, pancreas, and so many organs are Trans planted. This conference seek to bring all such Cardiologists, Therapists, Surgeons, Healthcare Agencies, Healthcare Professionals, Doctors, Registered Nurses and researcher or scientist, Noble Laureate, researcher, research scholar, students and people together who are involved in this field and provide them to discuss about their innovation, exchange ideas and interaction with each other.

Major Organ Donation Societies around the Globe

WHO Global Observatory on Donation and Transplantation (GODT)

Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT)

Donation and Transplantation Institute (DTI)

International Society for Heart and Lung Transplantation (ISHLT)

International Society for Organ Donation and Procurement (ISODP)

International Transplant Nurses Society (ITNS)

Transplantation Society of Australia and New Zealand

Australia: Organ and Tissue Authority

Philippines: National Kidney and Transplant institute

Japan: Japan Organ Transplant Network

Malaysia: Malaysia Society of Transplantation

Singapore: National Organ Transplant Unit

Saudi Arabia: Saudi Centre for Organ Transplantation

Middle East Society for Organ Transplantation (MESOT)

Israel: ADI - National Transplant Center

European Society of Transplantation

Belgian Transplantation Society

Denmark: Dansk Transplantationsselskab

France: French Federation for Organ Donation

Germany: Deutsche Stiftung Organtransplantation (DSO)

Greece: Hellenic National Transplant Organization

Italy: Centro Nazionale Trapianti (CNT)

Netherlands: Nederlandse Transplantatie Vereniging

Poland: Poltransplant

Spain: Organización Nacional de Trasplantes (ONT)

United Kingdom: National Health Service Blood and Transplant

Brazil: Coordenaçao -Geral do Sistema Nacional de Transplantes

Mexico: Centro Nacional de Trasplantes (CENATRA)

Canadian Blood Services – Organ and Tissue Donation and Transplantation

American Society of Transplantation (AST)

Target Audience:

The target audience will be Cardiologists, Therapists, Surgeons, Healthcare Agencies, Healthcare Professionals, Doctors, Registered Nurses and researcher or scientist who are researching in Organ Transplantation and Artificial Organs.

Meet Your Target Market With members from around the world focused on learning about Surgeons, this is your single best opportunity to reach the largest assemblage of participants from the all Over the World. Conduct demonstrations, distribute information, meet with current, make a splash with a new product line, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Organ Transplantation and Artificial Organs are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://organtransplantation.conferenceseries.com/sponsors.php

8^th International Conference on Tissue Science and Regenerative Medicine was hosted by the Conference Series LLC LTD at Singapore during September 11-12, 2017 with the theme “Explore and Exploit the Novel Techniques to Repair, Restore and Regenerate”.

The conference marked its start by an opening ceremony which included introduction by the Honorable Guests and the Members of Keynote Forum. All the speakers have extended their contribution in the form of highly informative presentations to lead the conference to the ladder of success.

Conference Series extends its warm gratitude towards all the Participants, Eminent Speakers, Young Researchers, Delegates and Students.

We would like to specially thank the following people who laid the foundation for the event’s success

Organizing Committee Members:

• Claire Henchcliffe- Director, Parkinson's Institute, Weill Cornell Medical Center, USA
• Tanongsak Panyawirunroj- Founder, Asia Cosmetic Hospital, Thailand
• Sergey Suchkov- Professor, I.M.Sechenov First Moscow State Medical University, Russia
• Denis Butnaru- Director, Institute for Regenerative Medicine (IRM), Russia
• Nelson R.Pinto- Professor, University of the Andes, Chile
• Alain Chapel- Professor, Institute of Radioprotection and Nuclear Safety (IRSN), France
• Jyh-Ping Chen- Professor, Chang Gung University, Taiwan
• Hicham Fenniri- Professor, Northeastern University, USA
• Giacomo Cao- Professor, University of Cagliari, Italy

Keynote Speakers:

• Claire Henchcliffe- Director, Parkinson's Institute, Weill Cornell Medical Center, USA
• Nadia Benkirane-Jessel- Research Director, Inserm - French National Institute of Health and Medical Research, France
• Tanongsak Panyawirunroj- Founder, Asia Cosmetic Hospital, Thailand
• Nelson Pinto- Professor, University of the Andes, Chile
• Debra Webster- Principal Scientist, Cardinal Health Regulatory Sciences, USA
• Leah Vardy- Principal Investigator, Institute of Medical Biology, A*STAR, Singapore

Moderator:

• Debra Webster- Principal Scientist, Cardinal Health Regulatory Sciences, USA
• Sergey Suchkov- I.M.Sechenov First Moscow State Medical University, Russia

After the huge optimistic response from scientific fraternity, renowned personalities and the Editorial Board Members of Conference Series LLC LTD Group from across the world we are pleased to announce the 8^th International Conference on Tissue Science and Regenerative Medicine to be held during July 19-20, 2018 at Melbourne, Australia.

Let us meet again @ Tissue Science Congress 2018